InvestorsHub Logo
Followers 15
Posts 542
Boards Moderated 0
Alias Born 01/13/2006

Re: None

Monday, 03/30/2015 3:23:14 PM

Monday, March 30, 2015 3:23:14 PM

Post# of 3356
Saturdays presentation available on the company website



Gynecological Cancer Treatment

Gynecologic Treatment Using Cesium-131 Provides the Following Advantages: Gynecologic Treatment

Deliver the dose where you want. When it’s needed.

Cesium-I3I has delivered 90% of the intended dose 33 days post implant, compared to 32% of the I-125 dose.
Cesium-I3I has delivered 99.8% of the dose at 90 days, when the sutures/mesh have most likely dissolved, compared to 65% for I-125.
Once the carrier material has dissolved, the seeds are free to migrate and stop contributing to the prescription dose plan.
Cesium-I3I delivers uniform and symmetrical radiation penetration for a homogeneous cervical implant.



Dr. Feddock’s Gynecologic Cancer Treatment Presentaion Part 1 03/28/2015.
Dr. Feddock’s Gynecologic Cancer Treatment Presentaion Part 2.
Dr. Feddock’s Gynecologic Cancer Treatment Presentaion Part 3.
Dr. Feddock’s Gynecologic Cancer Treatment Presentaion Part 4.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CATX News